相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Scan and Unlock: A Programmable DNA Molecular Automaton for Cell-Selective Activation of Ligand-Based Signaling
Jinghui Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Nongenetic control of receptor signaling dynamics using a DNA-based optochemical tool
Ryosuke Ueki et al.
CHEMICAL COMMUNICATIONS (2021)
Binding and Structural Properties of DNA Aptamers with VEGF-A-Mimic Activity
Toru Yoshitomi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application
Ryosuke Ueki et al.
SCIENCE ADVANCES (2020)
Aptamers with Tunable Affinity Enable Single-Molecule Tracking and Localization of Membrane Receptors on Living Cancer Cells
Pietro Delcanale et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Near-Infrared Light-Activated DNA-Agonist Nanodevice for Nongenetically and Remotely Controlled Cellular Signaling and Behaviors in Live Animals
Miao Wang et al.
NANO LETTERS (2019)
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
Kritika Mohan et al.
SCIENCE (2019)
Bispecific Aptamer Induced Artificial Protein-Pairing: A Strategy for Selective Inhibition of Receptor Function
Liping Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Logic-Gate-Actuated DNA-Controlled Receptor Assembly for the Programmable Modulation of Cellular Signal Transduction
Shan Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
DNA aptamer assemblies as fibroblast growth factor mimics and their application in stem cell culture
Ryosuke Ueki et al.
CHEMICAL COMMUNICATIONS (2019)
Light-Induced Activation of c-Met Signalling by Photocontrolled DNA Assembly
Shan Chen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner
Wenyu Miao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Nongenetic Reprogramming of the Ligand Specificity of Growth Factor Receptors by Bispecific DNA Aptamers
Ryosuke Ueki et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling
Chia Chi M. Ho et al.
CELL (2017)
Oligonucleotide-Based Mimetics of Hepatocyte Growth Factor
Ryosuke Ueki et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
Suman Mitra et al.
IMMUNITY (2015)
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga et al.
SCIENCE SIGNALING (2015)
Artificial human Met agonists based on macrocycle scaffolds
Kenichiro Ito et al.
NATURE COMMUNICATIONS (2015)
DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist
Vidhya Ramaswamy et al.
NUCLEIC ACID THERAPEUTICS (2015)
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga et al.
SCIENCE SIGNALING (2015)
A DNA aptamer to c-Met inhibits cancer cell migration
R. Ueki et al.
CHEMICAL COMMUNICATIONS (2014)
Understanding cytokine and growth factor receptor activation mechanisms
Mariya Atanasova et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Combined Transfer of Human VEGF165 and HGF Genes Renders Potent Angiogenic Effect in Ischemic Skeletal Muscle
Pavel Makarevich et al.
PLOS ONE (2012)
Orientation-specific signalling by thrombopoietin receptor dimers
Judith Staerk et al.
EMBO JOURNAL (2011)
Structural insights into Met receptor activation
Hartmut H. Niemann
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
David J. Riese
EXPERT OPINION ON DRUG DISCOVERY (2011)
Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety
Akio Ido et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
hHGF Overexpression in Myoblast Sheets Enhances Their Angiogenic Potential in Rat Chronic Heart Failure
Antti Siltanen et al.
PLOS ONE (2011)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MET signalling: principles and functions in development, organ regeneration and cancer
Livio Trusolino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Structural basis for agonism and antagonism of hepatocyte growth factor
W. David Tolbert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural Biology of Shared Cytokine Receptors
Xinquan Wang et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis
Marco Cassano et al.
PLOS ONE (2008)
Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor
Masayuki Kai et al.
NATURE BIOTECHNOLOGY (2008)
A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
W. David Tolbert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Autocrine production of biologically active hepatocyte growth factor (HGF) by injured human skin
F Nayeri et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
分享论文
